FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2012/02/002398 [Registered on: 02/02/2012] Trial Registered Retrospectively
Last Modified On: 31/12/2012
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Non-randomized, Multiple Arm Trial 
Public Title of Study   STARCH: Study To Assess the dietaRy CarboHydrate content of Indian diabetic population 
Scientific Title of Study   Epidemiological study to evaluate the dietary composition of Indian type-2 diabetic patients compared to non-diabetic population 
Trial Acronym  STARCH 
Secondary IDs if Any  
Secondary ID  Identifier 
NN1120IN  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
Modification(s)  
Name  DR SHASHANK R JOSHI 
Designation  CONSULTANT ENDOCRINE & METABOLIC PHYSICIAN 
Affiliation   
Address  12, GOLDEN PALACE,BEHIND UNION BANK,TURNER ROAD,BANDRA WEST,MUMBAI

Mumbai
MAHARASHTRA
400050
India 
Phone  9321024941  
Fax    
Email  shashank.sr@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Rahul Rathod 
Designation  Senior Medical Advisor 
Affiliation  Bayer Zydus Pharma Private Limited 
Address  Bayer Zydus Pharma Private Limited I Kolshet Road Thane India 400 607

Thane
MAHARASHTRA
400 607
India 
Phone  912225311431  
Fax  912225455007  
Email  rahul.rathod@bayerzyduspharma.com  
 
Details of Contact Person
Public Query
 
Name  Rahul Rathod 
Designation  Senior Medical Advisor 
Affiliation  Bayer Zydus Pharma Private Limited 
Address  Bayer Zydus Pharma Private Limited I Kolshet Road Thane India 400 607


MAHARASHTRA
400 607
India 
Phone  912225311431  
Fax  912225455007  
Email  rahul.rathod@bayerzyduspharma.com  
 
Source of Monetary or Material Support  
BayerZydus Pharma Pvt ltd Kolshet road,Thane - 400 607 Maharashtra 
 
Primary Sponsor  
Name  Bayer Pharmaceuticals 
Address  Bayer Pharma Private Limited, Kolshet Road, Thane, Maharashtra, India. Pin – 400607 
Type of Sponsor  Pharmaceutical industry-Global 
 
Details of Secondary Sponsor  
Name  Address 
NA  NA 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 10  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Mala Dharmalingam  Bangalore Endocrinology & Diabetes Research center  Dept of Endcrinology,35, 5th Cross, Malleshwaram Circle,Near Biz Bazaar, Next to Indian Bank, Bengaluru 560 003
Bangalore
KARNATAKA 
9845208163

endocrinology23@rediffmail.com 
Dr Sarita Bajaj  Dr. Sarita Bajaj  3/6,Panna lal road, Allahabad - 211 002,UP,India
Allahabad
UTTAR PRADESH 
9415239392

drsarita.bajaj@gmail.com 
Dr Subodh Banzal  Dr. Subodh Banzal  "107,Trade House, Opp Dhakkanwala Kua, South Tukoganj, INDORE."
Indore
MADHYA PRADESH 
9893693006

subodhbanzal@gmail.com 
Dr Swapan Sarkar  Dr. Swapan Sarkar  "Ganraj Chowmuhani, Banamalipur, P.O. Agartala , Tripura west ,PIN: 799007
North Tripura
TRIPURA 
9436120269

swapanagt1958@yahoo.com 
DrR K Sahay  Dr.R K Sahay  MY NEST"6-3-852/A,AMERPREET ,HYDERABAD - 500016
Hyderabad
ANDHRA PRADESH 
9849597507

sahayrk@gmail.com 
DrShachin Gupta  Dr.Shachin Gupta  "8/2,Sanjay complex, Near Mata Mandir, South T T Nagar Bhopal-462 003"
Bhopal
MADHYA PRADESH 
9425010103

shachinseema@yahoo.com 
Dr Parag Shah  Gujarat Endocrine Centre  201,2nd floor, Silver Brook-B, Opp. Doctor House, Nr. Parimal Crossing, Ellisbridge, Ahmedabad-380006.
Ahmadabad
GUJARAT 
9824042688

paragendocrine@yahoo.com 
DrSatinath Mukhopadhyay  Institute of Post Graduate Medical Education & Research   244,AJC Bose Road,Ronald Ross Building,4th Floor, Room No 9,Kolkata-700020
Kolkata
WEST BENGAL 
9830027985

satinath59@hotmail.com 
Dr Shashank Joshi  Joshi Clinic  Block 12, Golden Palace, Behind Union Bank, Turner Road, Bandra (W)- Mumbai-400050
Mumbai
MAHARASHTRA 
9820186302

shashank.sr@gmail.com 
Dr Anil Bansali  Post Graduate Institute of Medical Education & Research  Department of Endocrinology Chandiragh-160012
Chandigarh
CHANDIGARH 
9316977995

anilbhansali_endocrine@rediffmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 10  
Name of Committee  Approval Status 
Bangalore Endocrinology & Diabetes Research center Ethics Committee on Human Research ,Bangalore  Approved 
CLINICOM Bangalore - Dr Banzal  Approved 
CLINICOM Bangalore - Dr Gupta  Approved 
CLINICOM Bangalore - DR Sahay  Approved 
CLINICOM BANGALORE - Dr Sarkar  Approved 
CLINICOM Bangalore - Dr Shah  Approved 
CLINICOM Bangalore - Dr Shashank Joshi  Approved 
CLINICOM Bangalore -Dr Bajaj  Approved 
Institute Ethics Committee Post Graduate Institiute of Medical Education & Research,Chandigarh  Approved 
IPGME&R Research Oversight Committee,IPGMER Kolkata  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
No Objection Certificate 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Diabetic population and non diabetic populaion,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Diabetic Population
Patients willing to provide signed & dated informed consent and comply with study
Indian diabetic population diagnosed with T2DM for at least 12 months
Male and non pregnant female with age18 years or more
Non-Diabetic Population
Indian non-diabetic population who are not following any diet plan or dietary advice
Patients willing to provide signed & dated informed consent and comply with study requirements.
Male and non pregnant female with age 18 years or more
Non-diabetic population should be matched in terms of age, sex and centre
 
 
ExclusionCriteria 
Details  Patient unwilling to comply with the study procedures
Pregnant & lactating women
History of cardiovascular event within the previous six months
Patients with specific co morbidities, which may impact the patients diet, e.g malignant diseases, advanced dementia, Parkinson’s disease and others
Suffering from chronic diseases including but not limited to chronic renal failure, chronic liver disease that might interfere with participation in the study as per physician discretion.
Patients on weight management plan e.g. low carbohydrate diet which includes dietary modifications or dietary alterations
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Percentage of total energy intake as carbohydrate by Indian diabetic population
Percentage of complex carbohydrate intake from total carbohydrate by Indian diabetic population 
Time Frame: 1 day
Time Frame: 1 day 
 
Secondary Outcome  
Outcome  TimePoints 
Difference in the percentage of total energy intake as carbohydrate by diabetic versus non-diabetic population
Difference in the percentage of complex carbohydrate content of diabetic versus non-diabetic population
Difference in the percentage of total energy intake as proteins & fats by diabetics versus non-diabetic population
Percentage of diabetics population who follows diet plan
Percent of diabetic population with glycaemic control 
Time Frame: 1 day 
 
Target Sample Size   Total Sample Size="800"
Sample Size from India="800" 
Final Enrollment numbers achieved (Total)= ""
Final Enrollment numbers achieved (India)="" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   16/01/2012 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

-      There are few smaller studies from Southern part of India, sparing that we do not have larger studies which documents the dietary contents of diabetic patients.

-      There is a need to conduct dietary survey considering the diverse dietary food habits in various parts of India.

-      Interaction with KOL also suggested that merely only percentage of diabetic population actually follows the dietary advice (Diet Plan)

-      The purpose of the present cross-sectional study is to comprehend the dietary pattern of diabetics and also find out how it compare with non-diabetic population.

-      This study results should also help us to conclusively describe the role of a-glucosidase inhibitors like Glucobay in management protocol of diabetic patients in India, which is presently not considered as very essential for management of type-II diabetes mellitus.

-   In addition, the study results should also assist to define the effective strategy to address the role of a-glucosidase inhibitors in routine management of Indian diabetic patients 
Close